“Many thanks again for your professionalism and great help. I will definitely refer to my colleagues and friends. I would also like to specifically thank my attorney for his outstanding skills and help with my case. I really appreciate him.”

Case Summary:  

In the field of population health, where evidence meets action and policy stems from science, one internationally trained expert has recently marked an extraordinary milestone. With both the EB-2 National Interest Waiver and EB-1A Alien of Extraordinary Ability approvals in hand, this specialist from Myanmar stands as a powerful example of how data-driven solutions and global health priorities can align in ways that benefit not just one nation but communities worldwide.

A Scholar of Synthesis and Strategy

The client, currently employed as a specialist in the field of population health, has dedicated his career to improving healthcare systems through digital education, meta-analytical methods, and evidence synthesis. His work targets real-world challenges such as workforce shortages in health professions and the scalability of medical education. His research has evaluated how digital tools, like virtual reality (VR), augmented reality (AR), and digital problem-based learning, can bridge educational gaps, especially in underserved or remote settings.

Backed by rigorous analysis and data from randomized controlled trials, this specialist has built a strong portfolio of solutions that inform how healthcare professionals are trained. One recommender stated unequivocally: “His skillset is irreplaceable… It is imperative that he be allowed to carry out his research uninterrupted so that the United States is able to benefit fully from its value.”

Two Paths, One Outcome: National Interest and Extraordinary Talent

For the EB-2 NIW petition, the argument focused on the substantial merit and national importance of the applicant’s ongoing contributions. The case demonstrated how the research addressed public health workforce deficiencies through scalable training, while being supported by prestigious funding agencies and validated by publication in top-tier journals.

Meanwhile, the EB-1A petition highlighted a record of sustained acclaim. With 34 peer-reviewed articles (9 as first author), 2 technical reports, and over 3,900 citations, the client’s h-index of 27 places them in the top 1% of social science researchers globally. Impressively, at least 26 of his publications rank among the most highly cited for his publication year. The client has also completed over 33 peer reviews for renowned journals, further reinforcing his leadership in the field.

Global Impact, Local Benefit

What makes this case particularly compelling is the wide application of the client’s work. His studies have been cited by researchers from institutions including Johns Hopkins, Yale, and Texas Tech. Topics influenced range from behavioral training in mental health to VR-based empathy education for Parkinson’s disease care. Such citations serve not only as academic validation but also as evidence of real-world relevance.

Furthermore, the client’s planned research in the U.S.—focusing on evidence-based policymaking and data utilization for national health strategies—is designed to enhance clinical outcomes and inform sustainable public health infrastructure. These aims resonate strongly with the strategic needs of the United States.

From Recognition to Residency

With the EB-2 NIW petition filed in December 2024 and approved by February 2025, and the EB-1A petition filed in May 2025 and approved in just under two weeks by June 6, 2025, this case is not only a legal success but a testament to the powerful interplay of scientific impact, strategic planning, and regulatory alignment.

At NAILG, we are proud to have supported a case that exemplifies what U.S. immigration policy was designed to do: attract and retain the best minds working on the world’s most urgent problems. This dual approval confirms that extraordinary contributions to public health are not just recognized—they are welcomed.